Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Mite Asthma Pediatric Immunotherapy Trial

ClinicalTrials.gov ID: NCT03654976

Public ClinicalTrials.gov record NCT03654976. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 4:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Trial Evaluating the Efficacy and Safety of the House Dust Mite (HDM) Sublingual Immunotherapy (SLIT)-Tablet in Children and Adolescents (5-17 Years) With HDM Allergic Asthma

Study identification

NCT ID
NCT03654976
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ALK-Abelló A/S
Industry
Enrollment
533 participants

Conditions and interventions

Eligibility (public fields only)

Age range
5 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 21, 2018
Primary completion
May 17, 2022
Completion
May 30, 2022
Last update posted
Oct 18, 2023

2018 – 2022

United States locations

U.S. sites
7
U.S. states
5
U.S. cities
7
Facility City State ZIP Site status
Miami Clinical Research Miami Florida 33155
Columbus Regional Research Institute Columbus Georgia 31904
Respiratory Medicine Research Institute of MI Ypsilanti Michigan 48197
Private Clinic Bangor Pennsylvania 04401
Allergy Consultants Verona Pennsylvania 07044
TTS research Boerne Texas 78006
STAAMP Research San Antonio Texas 78251

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 57 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03654976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 18, 2023 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03654976 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →